SUPN - Latest News
Supernus Pharmaceuticals, Inc. (SUPN), operates in Healthcare / Drug Manufacturers - Specialty & Generic, trades on NASDAQ.
Market capitalization stands near $2.80B. Beta to the broader market is 0.56.
The article list below shows the most recent SUPN headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent SUPN Headlines
Supernus Pharmaceuticals, Inc. $SUPN Shares Purchased by Bank of America Corp DE
defenseworld.net - Aug 15, 2026
Bank of America Corp DE lifted its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) by 37.
Supernus Pharmaceuticals, Inc. $SUPN Shares Sold by Assenagon Asset Management S.A.
defenseworld.net - Aug 13, 2026
Assenagon Asset Management S. A.
California State Teachers Retirement System Grows Stock Holdings in Supernus Pharmaceuticals, Inc. $SUPN
defenseworld.net - Aug 9, 2026
California State Teachers Retirement System lifted its stake in Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) by 26.
Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders?
prnewswire.com - Aug 7, 2026
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securi
SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?
zacks.com - Aug 7, 2026
Investors with an interest in Medical - Generic Drugs stocks have likely encountered both Supernus Pharmaceuticals (SUPN) and Teva Pharmaceutical Indu
How News Affects SUPN Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track SUPN's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked SUPN news questions
- What is the latest SUPN news headline?
- The most recent SUPN headline (Aug 15, 2026) is "Supernus Pharmaceuticals, Inc. $SUPN Shares Purchased by Bank of America Corp DE". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the SUPN news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What SUPN news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual SUPN options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.